These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6404619)

  • 21. [Development of an oral nitroglycerin proxyphyllin retard compound].
    Ritschel WA; Clotten R
    Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053
    [No Abstract]   [Full Text] [Related]  

  • 22. Apparent stability of nitroglycerin in dextrose 5% in water.
    Ludwig DJ; Ueda CT
    Am J Hosp Pharm; 1978 May; 35(5):541-4. PubMed ID: 418679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability study of nitroglycerin sublingual tablets.
    Page DP; Carson NA; Buhr CA; Flinn PE; Wells CE; Randall MT
    J Pharm Sci; 1975 Jan; 64(1):140-7. PubMed ID: 805832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plastic i.v. container for nitroglycerin.
    Amann AH; Baaske DM; Wagenknecht DM
    Am J Hosp Pharm; 1980 May; 37(5):618. PubMed ID: 6770680
    [No Abstract]   [Full Text] [Related]  

  • 25. Sublingual nitroglycerin. I. Comparative evaluation of the physical stability of commercially available tablets.
    Lagas M; Duchateau AM
    Pharm Weekbl Sci; 1988 Dec; 10(6):246-53. PubMed ID: 3145487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific high-performance liquid chromatographic assay for nitroglycerin in dosage forms.
    Crouthamel WG; Dorsch B
    J Pharm Sci; 1979 Feb; 68(2):237-8. PubMed ID: 106106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of nitroglycerin from aqueous solution into plastic intravenous delivery systems.
    Yuen PH; Denman SL; Sokoloski TD; Burkman AM
    J Pharm Sci; 1979 Sep; 68(9):1163-6. PubMed ID: 115988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous nitroglycerin: a review.
    Baaske DM; Yacobi A; Amann AH
    Am Pharm; 1982 Feb; NS22(2):36-9. PubMed ID: 6800249
    [No Abstract]   [Full Text] [Related]  

  • 29. Stability of nitroglycerin injection determined by gas chromatography.
    Sturek JK; Sokoloski TD; Winsley WT; Stach PE
    Am J Hosp Pharm; 1978 May; 35(5):537-41. PubMed ID: 418678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proper packaging and storage of nitroglycerin tablets.
    Shangraw RF
    Am J Hosp Pharm; 1972 May; 29(5):386. PubMed ID: 4624697
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of infusion administration set on the delivery rate and plasma concentration of nitroglycerin in dogs.
    McNiff EF; Lai CM; Look ZM; Yacobi A; Fung HL
    J Pharm Sci; 1985 Jul; 74(7):774-6. PubMed ID: 3928871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatographic determination of nitroglycerin in sublingual, sustained-release, and ointment dosage forms.
    Olsen CS; Scroggins HS
    J Pharm Sci; 1983 Aug; 72(8):963-5. PubMed ID: 6413677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of nitroglycerin from solutions to intravenous plastic containers: a theoretical treatment.
    Malick AW; Amann AH; Baaske DM; Stoll RG
    J Pharm Sci; 1981 Jul; 70(7):798-800. PubMed ID: 6790697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid high-performance liquid chromatographic procedure for nitroglycerin and its degradation products.
    Severin G
    J Chromatogr; 1985 Mar; 320(2):445-9. PubMed ID: 3928663
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug migration from the adhesive matrix to the polymer film laminate facestock in a transdermal nitroglycerin system.
    Markovich RJ; Taylor AK; Rosen J
    J Pharm Biomed Anal; 1997 Dec; 16(4):651-60. PubMed ID: 9502161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Open-Label Study of the Stability of Sublingual Nitroglycerin Tablets in Simulated Real-Life Conditions.
    Nawarskas JJ; Koury J; Lauber DA; Felton LA
    Am J Cardiol; 2018 Dec; 122(12):2151-2156. PubMed ID: 30314813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrate delivery systems in perspective. A decade of progress.
    Abrams J
    Am J Med; 1984 Jun; 76(6A):38-46. PubMed ID: 6430076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incomplete and delayed bioavailability of sublingual nitroglycerin.
    Noonan PK; Benet LZ
    Am J Cardiol; 1985 Jan; 55(1):184-7. PubMed ID: 3917598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The stability of glyceryl trinitrate tablets during patient use.
    Marty J; Shaw J; Hunt D
    Aust N Z J Med; 1983 Apr; 13(2):147-50. PubMed ID: 6412672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: Development of a stable sublingual nitroglycerin tablet I: interaction of nitroglycerin with selected macromolecules.
    Fung HL; Yap SK; Rhodes CT
    J Pharm Sci; 1974 Nov; 63(11):1810-2. PubMed ID: 4214916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.